Withdrawn
Review of cancer drugs for chronic lymphocytic leukaemia
Condition
Blood and Immune System
Cancer
2 January 2024
Published on 12 Jul 2022
Last Updated on 02 Jan 2024
Review of cancer drugs for chronic lymphocytic leukaemia Guidance is outdated and has been withdrawn on 2 Jan 2024.
The Plain English Summary (PES) has been updated on 2 Jan 2024.
Review of cancer drugs for chronic lymphocytic leukaemia (Withdrawn 2 Jan 2024) [PDF, 257 KB]
PES Treatments for chronic lymphocytic leukaemia (Updated 2 Jan 2024) [PDF, 177 KB]